Hypoglycemia is the principal adverse event associated with the pharmacologic management of type 2 diabetes mellitus, and it frequently limits the effectiveness of therapy. Our preliminary studies suggest that sub-intoxicating doses of ethanol are an important mechanism for the development of sulfonylurea-associated hypoglycemia in elderly patients with type 2 diabetes. The purpose of this proposal is to provide rationale for expanded studies into the pathophysiologic effects of ethanol among individuals with type 2 diabetes. I hypothesize that moderate doses of ethanol predispose sulfonylurea-treated patients with type 2 diabetes to hypoglycemic vulnerability by altering one or more of the physiologic processes critical to the defense against hypoglycemia, including (1) direct suppression of counterregulatory hormone release, (2) direct or indirect suppression of hepatic glucose production, and/or (3) reduction of gastrointestinal function with a subsequent delay in carbohydrate absorption. Additionally, I hypothesize that (4) aging will exacerbate the pro-hypoglycemic effects of ethanol, and that (5) the timing of ethanol ingestion relative to meal ingestion will at least partially determine its hypoglycemic potential. To address these hypotheses, I plan to compare the effects of low doses of intravenously and orally administered ethanol on counterregulatory hormone release and recovery from insulin-induced hypoglycemia to placebo among healthy subjects and subjects with type 2 diabetes. Additionally, the effects of administration of intravenous ethanol or its metabolite acetate on parameters of hepatic glucose turnover and lipolysis will be compared to placebo in subjects with type 2 diabetes. I will further examine parameters of gastric motility and function following intravenous and oral administration of ethanol or placebo in subjects with type 2 diabetes and will also compare the metabolic and hormonal responses to moderate doses of ethanol between young and elderly patients with type 2 diabetes mellitus matched for duration of disease. Finally, the effect of ethanol administration with a meal on parameters of overnight glucose homeostasis will be compared to ethanol administration 4 hours after meal ingestion in subjects with type 2 diabetes. These studies will explore clinically important questions that will enhance our understanding of hypoglycemia in type 2 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23DK002680-01
Application #
2878045
Study Section
Special Emphasis Panel (ZDK1-GRB-4 (M5))
Program Officer
Hyde, James F
Project Start
1999-09-30
Project End
2002-08-31
Budget Start
1999-09-30
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of New Mexico
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Burge, Mark R; Gabaldon-Bates, Janeen (2003) The role of ethnicity in post-pancreatitis diabetes mellitus. Diabetes Technol Ther 5:183-8
Burge, M R; Garcia, N; Qualls, C R et al. (2001) Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis. Metabolism 50:171-7
Burge, M R; Sobhy, T A; Qualls, C R et al. (2001) Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms. J Clin Endocrinol Metab 86:5471-8
Sood, V; Costello, B A; Burge, M R (2001) How low can you go? Chronic hypoglycemia versus normal glucose homeostasis. J Investig Med 49:205-9
Burge, M R; Tuttle, M S; Violett, J L et al. (2000) Breath hydrogen testing identifies patients with diabetic gastroparesis. Diabetes Care 23:860-1
Burge, M R; Tuttle, M S; Violett, J L et al. (2000) Potato-lactulose breath hydrogen testing as a function of gastric motility in diabetes mellitus. Diabetes Technol Ther 2:241-8
Burge, M R; Kamin, J R; Timm, C T et al. (2000) Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes. Metabolism 49:195-202
Burge, M R; Zeise, T M; Sobhy, T A et al. (1999) Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose. Diabetes Care 22:2037-43